H.C. Wainwright analyst Yi Chen lowered the firm’s price target on Sensus Healthcare to $8 from $10 and keeps a Buy rating on the shares. The company’s sales are recovering with profitability expected in the second half of 2023, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SRTS:
- Sensus Healthcare reports Q2 EPS (2c), consensus (8c)
- Sensus Healthcare Reports Second Quarter 2023 Financial Results
- Sensus Healthcare to Host Second Quarter 2023 Financial Results and Business Update Conference Call on Thursday, August 3, 2023
- Sensus Healthcare Completes Installation of its First SRT System in Ireland
- Sensus Healthcare completes installation of first SRT system in Ireland